Retrospective, Multicenter, Single-arm, Observational Study, With Data From Patients With T2DM Wi⦠(NCT06866366) | Clinical Trial Compass
CompletedNot Applicable
Retrospective, Multicenter, Single-arm, Observational Study, With Data From Patients With T2DM With Malnutrition or at Risk, Who Were Prescribed ResourceĀ® Diabet Plus as a Hypercaloric and Hyperproteic Specific Formula for Patients With T2DM
Spain59 participantsStarted 2025-04-23
Plain-language summary
This retrospective multicentre study aims to provide real-world evidence of the effectiveness of ResourceĀ® Diabet Plus as supplementation tool for T2DM patients with malnutrition or at risk of malnutrition, under conditions of routine clinical practice in Spain.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients ā„ 18 years.
* Outpatients or hospitalised patients, at discharge with a diagnosis of type 2 Diabetes.
* Patients at risk of malnutrition detected by validated screening tools or with DRM diagnosed by GLIM criteria.
* Patients who have been prescribed 1-2 bottles/day of ResourceĀ® Diabet Plus following the conditions of use of its technical data sheet, in the last 2 years, with at least 24 weeks of evolution recorded in the clinical history.
* Patients who have Hb1Ac data in the medical record on the index date and during evolution.
Exclusion Criteria:
* Pregnant or breastfeeding women.
* Patients who required any other type of nutritional supplementation during the study period (parenteral/enteral).
* Patients with severe renal insufficiency (glomerular filtration rate \< 30mL/min/1.73m2) at the time of selection.